Author:
Sairenji Motonori,Yanoma Shunsuke,Motohashi Hisahiko,Kobayashi Osamu,Okada Kenzou,Okamoto Takashi,Tsukuda Mamoru,Umeda Makoto
Publisher
Springer Science and Business Media LLC
Reference17 articles.
1. Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA Lymphokine-activated killer cells: Lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2. Cancer Res 1984; 44: 1946–1953.
2. Rosenberg SA Lymphokine-activated killer cells: A new approach to immunotherapy of cancer. J Natl Cancer Inst 1985; 75: 595–603.
3. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA Lymphokine-activated killer cell phenomenon lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155: 1823–1841.
4. Mule JJ, Shu S, Schwarz SL, Rosenberg SA Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 1984; 225: 1487–1489.
5. Rosenberg SA, Lotze MT, Muul LM, Leitman SL, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seipp CA, Simpson C, Reichert CM Observations on the systemic administration of autolog- ous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. New Engl J Med 1985; 313: 1485–1492.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献